Westport Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.42M | Hold |
7,500
| – | – | 0.58% | 39 |
|
|
2026
Q1 | $1.48M | Hold |
7,500
| – | – | 0.65% | 38 |
|
|
2025
Q4 | $1.15M | Hold |
7,500
| – | – | 0.48% | 38 |
|
|
2025
Q3 | $1.15M | Hold |
7,500
| – | – | 0.48% | 38 |
|
|
2025
Q2 | $1.05M | Hold |
7,500
| – | – | 0.46% | 40 |
|
|
2025
Q1 | $1.1M | Hold |
7,500
| – | – | 0.53% | 37 |
|
|
2024
Q4 | $983K | Hold |
7,500
| – | – | 0.47% | 39 |
|
|
2024
Q3 | $1.17M | Hold |
7,500
| – | – | 0.55% | 35 |
|
|
2024
Q2 | $1.17M | Hold |
7,500
| – | – | 0.59% | 35 |
|
|
2024
Q1 | $1.02M | Hold |
7,500
| – | – | 0.51% | 37 |
|
|
2023
Q4 | $1.01M | Hold |
7,500
| – | – | 0.54% | 38 |
|
|
2023
Q3 | $1.02M | Hold |
7,500
| – | – | 0.6% | 38 |
|
|
2023
Q2 | $1.07M | Hold |
7,500
| – | – | 0.6% | 40 |
|
|
2023
Q1 | $1.04M | Hold |
7,500
| – | – | 0.63% | 38 |
|
|
2022
Q4 | $1.02M | Hold |
7,500
| – | – | 0.65% | 36 |
|
|
2022
Q3 | $823K | Hold |
7,500
| – | – | 0.52% | 39 |
|
|
2022
Q2 | $991K | Hold |
7,500
| – | – | 0.59% | 36 |
|
|
2022
Q1 | $874K | Hold |
7,500
| – | – | 0.4% | 45 |
|
|
2021
Q4 | $874K | Hold |
7,500
| – | – | 0.4% | 45 |
|
|
2021
Q3 | $901K | Hold |
7,500
| – | – | 0.44% | 42 |
|
|
2021
Q2 | $899K | Hold |
7,500
| – | – | 0.4% | 44 |
|
|
2021
Q1 | $746K | Hold |
7,500
| – | – | 0.34% | 46 |
|
|
2020
Q4 | $750K | Hold |
7,500
| – | – | 0.37% | 43 |
|
|
2020
Q3 | $822K | Hold |
7,500
| – | – | 0.5% | 37 |
|
|
2020
Q2 | $793K | Hold |
7,500
| – | – | 0.51% | 37 |
|
|
2020
Q1 | $670K | Hold |
7,500
| – | – | 0.55% | 36 |
|
|
2019
Q4 | $748K | Hold |
7,500
| – | – | 0.51% | 30 |
|
|
2019
Q3 | $669K | Hold |
7,500
| – | – | 0.48% | 33 |
|
|
2019
Q2 | $619K | Buy |
7,500
+2,500
| +50% | +$196K | 0.42% | 35 |
|
|
2019
Q1 | $404K | Hold |
5,000
| – | – | 0.28% | 43 |
|
|
2018
Q4 | $380K | Hold |
5,000
| – | – | 0.32% | 40 |
|
|
2018
Q3 | $350K | Hold |
5,000
| – | – | 0.25% | 43 |
|
|
2018
Q2 | $350K | Hold |
5,000
| – | – | 0.25% | 43 |
|
|
2018
Q1 | $350K | Hold |
5,000
| – | – | 0.25% | 42 |
|
|
2017
Q4 | $341K | Hold |
5,000
| – | – | 0.26% | 43 |
|
|
2017
Q3 | $341K | Buy |
5,000
+2,500
| +100% | +$158K | 0.26% | 44 |
|
|
2017
Q2 | $170K | Buy |
+2,500
| New | +$163K | 0.15% | 46 |
|
Other funds holding AZN
EP
IA
Westport Asset Management's AZN Position: Q2 2026 in Review
Westport Asset Management held its AstraZeneca (AZN) position steady in Q2 2026 at 7,500 shares worth $1.42M. The position accounts for 0.58% of the portfolio, ranked #39.
Westport Asset Management first reported a position in AZN in Q2 2017 and has held it in 37 quarters since. The position peaked at $1.48M in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Westport Asset Management held 7,500 shares of AstraZeneca worth $1.42M as of Q2 2026.
- Westport Asset Management left its AstraZeneca share count unchanged in Q2 2026.
- AstraZeneca made up 0.58% of Westport Asset Management's portfolio in Q2 2026, its #39 holding.
- Westport Asset Management first reported a position in AstraZeneca in Q2 2017 and has held it in 37 quarters since.
- Westport Asset Management's AstraZeneca position peaked at $1.48M in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Westport Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.